Old National Bancorp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
5,123
+12
+0.2% +$4.45K 0.04% 232
2026
Q1
$1.5M Sell
5,111
-872
-15% -$287K 0.03% 270
2025
Q4
$2.1M Buy
5,983
+47
+0.8% +$15.9K 0.03% 244
2025
Q3
$1.92M Sell
5,936
-331
-5% -$103K 0.03% 247
2025
Q2
$2.44M Buy
6,267
+1,939
+45% +$780K 0.04% 229
2025
Q1
$1.88M Buy
4,328
+236
+6% +$94.7K 0.05% 206
2024
Q4
$1.51M Sell
4,092
-721
-15% -$302K 0.04% 244
2024
Q3
$2.5M Buy
4,813
+74
+2% +$39.5K 0.06% 208
2024
Q2
$2.57M Sell
4,739
-168
-3% -$88.8K 0.06% 200
2024
Q1
$2.54M Sell
4,907
-435
-8% -$216K 0.06% 202
2023
Q4
$2.52M Buy
5,342
+110
+2% +$50.9K 0.07% 200
2023
Q3
$2.28M Sell
5,232
-311
-6% -$141K 0.07% 201
2023
Q2
$2.46M Sell
5,543
-1,599
-22% -$738K 0.07% 202
2023
Q1
$3.28M Buy
7,142
+32
+0.5% +$15.2K 0.1% 173
2022
Q4
$3.65M Sell
7,110
-433
-6% -$220K 0.11% 162
2022
Q3
$3.43M Sell
7,543
-188
-2% -$90K 0.12% 165
2022
Q2
$3.73M Buy
7,731
+2,490
+48% +$1.23M 0.13% 159
2022
Q1
$2.58M Sell
5,241
-182
-3% -$83.2K 0.1% 165
2021
Q4
$2.51M Buy
5,423
+624
+13% +$263K 0.09% 170
2021
Q3
$1.79M Sell
4,799
-4,200
-47% -$1.6M 0.07% 198
2021
Q2
$3.44M Sell
8,999
-324
-3% -$124K 0.13% 156
2021
Q1
$3.35M Sell
9,323
-397
-4% -$128K 0.13% 153
2020
Q4
$3.12M Sell
9,720
-1,371
-12% -$421K 0.13% 145
2020
Q3
$2.98M Sell
11,091
-617
-5% -$166K 0.14% 137
2020
Q2
$3.08M Buy
11,708
+261
+2% +$69.6K 0.16% 136
2020
Q1
$2.6M Buy
11,447
+620
+6% +$169K 0.16% 137
2019
Q4
$3.27M Sell
10,827
-1,961
-15% -$540K 0.16% 138
2019
Q3
$3.07M Buy
12,788
+761
+6% +$209K 0.15% 145
2019
Q2
$3.39M Buy
12,027
+2,755
+30% +$753K 0.17% 134
2019
Q1
$2.66M Sell
9,272
-1,108
-11% -$320K 0.14% 148
2018
Q4
$2.73M Buy
10,380
+704
+7% +$194K 0.15% 143
2018
Q3
$2.65M Buy
9,676
+60
+0.6% +$15.6K 0.13% 159
2018
Q2
$2.29M Sell
9,616
-25
-0.3% -$5.79K 0.12% 164
2018
Q1
$2.12M Sell
9,641
-965
-9% -$227K 0.11% 169
2017
Q4
$2.39M Sell
10,606
-290
-3% -$61.8K 0.12% 147
2017
Q3
$2.07M Hold
10,896
0.11% 157
2017
Q2
$2.05M Sell
10,896
-588
-5% -$106K 0.11% 150
2017
Q1
$1.9M Buy
11,484
+1,721
+18% +$274K 0.1% 161
2016
Q4
$1.4M Buy
9,763
+1,798
+23% +$241K 0.08% 201
2016
Q3
$998K Sell
7,965
-1,036
-12% -$134K 0.06% 238
2016
Q2
$1.18M Sell
9,001
-1,356
-13% -$186K 0.07% 209
2016
Q1
$1.44M Sell
10,357
-937
-8% -$125K 0.08% 181
2015
Q4
$1.57M Buy
11,294
+1,686
+18% +$232K 0.09% 156
2015
Q3
$1.34M Sell
9,608
-2,537
-21% -$381K 0.08% 177
2015
Q2
$1.99M Sell
12,145
-4,982
-29% -$796K 0.11% 141
2015
Q1
$2.65M Buy
17,127
+2,837
+20% +$404K 0.14% 122
2014
Q4
$1.8M Sell
14,290
-1,324
-8% -$164K 0.11% 133
2014
Q3
$1.87M Buy
15,614
+353
+2% +$40.5K 0.12% 129
2014
Q2
$1.64M Buy
15,261
+1,137
+8% +$117K 0.12% 115
2014
Q1
$1.41M Buy
14,124
+3,594
+34% +$325K 0.13% 100
2013
Q4
$973K Buy
10,530
+736
+8% +$65.4K 0.09% 99
2013
Q3
$819K Buy
9,794
+522
+6% +$44.7K 0.08% 96
2013
Q2
$759K Buy
+9,272
New +$694K 0.08% 98

Other funds holding ELV

Old National Bancorp's ELV Position: Q2 2026 in Review

Old National Bancorp increased its Elevance Health (ELV) stake by 0.23% in Q2 2026, buying an estimated $4.45K and bringing the position to 5,123 shares worth $1.98M. The position accounts for 0.04% of the portfolio, ranked #232.

Old National Bancorp first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.73M in Q2 2022. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Old National Bancorp held 5,123 shares of Elevance Health worth $1.98M as of Q2 2026.
  • Old National Bancorp bought 12 Elevance Health shares in Q2 2026, an estimated $4.45K.
  • Elevance Health made up 0.04% of Old National Bancorp's portfolio in Q2 2026, its #232 holding.
  • Old National Bancorp first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Old National Bancorp's Elevance Health position peaked at $3.73M in Q2 2022.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.